Dexcom (DXCM) Treasury Shares (2011 - 2026)

Dexcom (DXCM) has 9 years of Treasury Shares data on file, last reported at $2.1 billion in Q1 2026.

• Treasury Shares for Q1 2026 came in at $2.1 billion, up 34.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 34.11% YoY), and the FY2025 annual result was $2.1 billion, up 31.85% from the prior year.
• Treasury Shares advanced to $2.1 billion in Q1 2026 per DXCM's latest filing, from $2.1 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $26.4 million in Q1 2026 and troughed at $100000.0 in Q1 2022.
• A 5-year average of $11.2 million and a median of $7.8 million in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares tumbled 62.7% in 2022, then soared 2002.14% in 2023.
• A 5-year view of Treasury Shares shows it stood at $595.0 million in 2022, then soared by 311.95% to $2.5 billion in 2023, then slumped by 35.49% to $1.6 billion in 2024, then jumped by 31.85% to $2.1 billion in 2025, then grew by 1.72% to $2.1 billion in 2026.
• Business Quant data shows DXCM's Treasury Shares at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $1.8 billion in Q3 2025.